Numerous studies have shown a high potential of lipocalin-2 [15,16,17], endothelin-1 [19,20,21,22] and NT-proBNP [24,25,26] in predicting the severity of AKI and cardiac complications, which is why these biomarkers represent potential candidates for usage in HFRS patients’ monitoring. Here, NPPB is linked to acute kidney injury.